Prescription Drugs · Oncology Therapeutics
Bristol Myers Squibb: Ownership & structure
Bristol Myers Squibb operates through 7 legal entities in 5 countries.
Data updated Nov 21, 2026 · Back to the company report
Owners & entities
Bristol Myers Squibb operates through 7 legal entities in 5 countries.
Legal entities7 in 5 countries
Bristol-Myers Squibb Company
operator · US EIN 220790350
US
BRISTOL-MYERS SQUIBB FOUNDATION INC
related · US EIN 133127947
US
Oy Bristol-Myers Squibb Finland Ab
related
FI
ORG-0019
related
IT
3 more records: legal entities with their register numbers and links to each registerProUnlockor this company alone for 30 days · 50 credits
Subsidiaries in its annual report: 231 in 52 jurisdictions · United States 97, United Kingdom 15, Switzerland 14, Netherlands 13, Ireland 12 · sec.gov ↗
Stakes and purchases
Large holders (13D / 13G)holders of 5% or more, their newest filing
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months
Insiders bought $0 (0 people) and sold $2.3M (3 people) in the last 12 months.
Sold · EVP,Chief Med Offr,Head of Dev
6,249 shares at $64.57 · Sep 2026
$403k
Sold · SVP and Controller
500 shares at $67.50 · Aug 2026
$34k
Sold · EVP, Chief Financial Officer
25,519 shares at $61.60 · Apr 2026
$1.6M
Sold · EVP, Chief Financial Officer
4,481 shares at $62.05 · Apr 2026
$278k
Holders and shares as each register or filing states them.
Connections
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

Rho Capital PartnersVia a fund

venBio PartnersVia a fund

Nextech InvestVia a fund
63 portfolio companies: Zymeworks, Vividion Therapeutics (Acquired), Zenith Therapeutics and 60 more

Kleiner PerkinsVia a fund

NEAVia a fund
672 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
